ITCI

Intra-Cellular Therapies Inc.

Delisted

ITCI was delisted on the 1st of April, 2025.

170 hedge funds and large institutions have $2.3B invested in Intra-Cellular Therapies Inc. in 2021 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 50 increasing their positions, 66 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
170
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$22.7M
Puts
$18.3M
Net Calls
Net Calls Change

Top Buyers

1 +$72M
2 +$39.6M
3 +$11.5M
4
Invesco
Invesco
Georgia
+$9.53M
5
BlackRock
BlackRock
New York
+$8.81M

Top Sellers

1 -$27M
2 -$15.3M
3 -$13.4M
4
SC
Samlyn Capital
New York
-$9.85M
5
Norges Bank
Norges Bank
Norway
-$8.36M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$4.41M
52
$4.24M
53
$4.07M
54
$3.98M
55
$3.96M
56
$3.74M
57
$3.42M
58
$3.4M
59
$3.25M
60
$3.23M
61
$3.2M
62
$3.19M
63
$3.14M
64
$3M
65
$2.82M
66
$2.7M
67
$2.67M
68
$2.46M
69
$2.44M
70
$2.29M
71
$2.28M
72
$2.16M
73
$2.09M
74
$2.04M
75
$1.79M